NDA Group

Welcome to NDA Group

Europe’s leading regulatory drug development, pharmacovigilance and HTA consultancy

We support life science companies all over the world and across all phases of development, from pre-clinical to post marketing, to the needs and requirements of regulators and payers alike. We work together with our clients to address key strategic regulatory and reimbursement challenges. Our scientific expertise covers all major therapeutic areas.

The advice you get from NDA is from real experts in the industry, many who have been involved in shaping today’s regulatory, HTA and pharmacovigilance environment. We have close to 100 employees across Europe. More than 25% are ex EU regulators.

With our support, you can cut the time and associated cost it takes to get your products to market, and keep them there.

NDA supported more than 38% of the new medicinal products that were approved in the EU in 2014.


Regulatory
Affairs
More +
Pharmacovigilance
and Quality
More +
Health Technology
Assessment
More +
NDA Advisory
Board
More +

Expert Spotlight

Gopalan Narayanan   |   Biologics and Advanced Therapy Expert

More +
Gopalan Narayanan How Narayanan can help your Business

Dr. Narayanan has substantial experience in the area of biologics, advanced therapies and biosimilars. He has dual specialist postgraduate qualification in general internal medicine and pharmaceutical medicine. He was Manager of the Biotechnology unit at MHRA and Expert Medical Assessor and he is on the scientific editorial board of Gene Therapy Clinical Development journal. Narayanan can assist you with any support clients require in regulatory science aspects of life-cycle management in the field of Advanced Therapies and other complex biologics, with particular expertise in clinical development.


More +

Latest News from NDA

  • Pieter_Neels Dr Pieter Neels speaks at Pharmaceutical Law Workshop in Hanoi, Vietnam
    Dr Neels, NDA Group Clinical Expert and Advisory Board member, has been invited to present at Pharma Group - the Pharmac… Read more
    NLSDAYS-Logo_2015 Meet NDA at Nordic Life Science Days 9-10 September
    Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing toge… Read more
    Felix Lobo Félix Lobo chairman of the 15th Spanish Pharmaceutical Industry Meeting
    Professor Lobo, NDA Advisory Board member, is organizing and chairing the 15th Spanish Pharmaceutical Industry Meeting i… Read more
  • Dr Thomas Lönngren NDA's Thomas Lönngren participates in an EU-Global Regulatory workshop
    Dr. Thomas Lönngren, Strategic Advisor NDA Group, will present and participate in the session and workshop 'In Conversat… Read more
    Dr Thomas Lönngren Dr. Lönngren speaks on emerging trends in drug development at ARCS
    Dr. Thomas Lönngren, Strategic Advisor to NDA Group and former Executive Director of the European Medicines Agency (EMA)… Read more
    Untitled14 Helen Powell authors REMs article for QUASAR
    Helen Powell, Principal Consultant at NDA Group, has authored an article on behalf of the RQA Good Pharmacovigilance Pra… Read more
We make sure that men, women and children all over the world get access
to the best possible medicines without unnecessary delay.